Catalio Capital Management
Raju Kucherlapati is a venture partner at Catalio Capital Management. Raju has also been a professor at Harvard Medical School for 21 years, a founder and member of the board of directors at KEW Group for 12 years and 6 months, a member of the board of directors at Metamark Genetics for 12 years, a member of the board of directors at AVEO Pharmaceuticals for 19 years, and a scientific director at Harvard Partners Center for Genetics and Genomics for 7 years. Raju has also been a member of AACR for 7 years, a member of the board of directors at Enlight Biosciences for 2 years, and a professor at University of Illinois College of Medicine and Princeton University.
Raju Kucherlapati attended Yale University as a Fellow from 1972-1975, where they studied genetics in the Department of Biology. Raju then attended the University of Illinois Urbana-Champaign from 1967-1972 as a PhD student in genetics.
Raju Kucherlapati is a venture partner at Flagship Pioneering.
This person is not in any offices
Catalio Capital Management
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.